Forte Biosciences Ownership | Who Owns Forte Biosciences?

Forte Biosciences Ownership Summary

Forte Biosciences is owned by 15.23% institutional investors, 4.97% insiders, and 79.80% retail investors. Fred alger management is the largest institutional shareholder, holding 13.93% of FBRX shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 5.08% of its assets in Forte Biosciences shares.

FBRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Forte Biosciences	15.23%	4.97%	79.80%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fred alger management	1.64M	13.93%	$24.54M
Orbimed advisors	1.20M	10.19%	$17.95M
Federated hermes	1.77M	9.92%	$48.15M
Tybourne capital management (hk)	786.65K	6.70%	$11.80M
Cable car capital	500.00K	4.26%	$7.50M
Sphera funds management	474.31K	4.04%	$7.11M
Vanguard group	582.26K	3.27%	$15.88M
Adage capital partners gp	333.33K	2.84%	$5.00M
Woodline partners lp	331.99K	2.83%	$4.98M
Ikarian capital	300.00K	2.55%	$4.50M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tybourne capital management (hk)	786.65K	38.15%	$11.80M
Cable car capital	500.00K	3.21%	$7.50M
Sphera funds management	474.31K	1.50%	$7.11M
Awm investment company	236.82K	0.62%	$6.46M
Ikarian capital	300.00K	0.45%	$4.50M
Orbimed advisors	1.20M	0.42%	$17.95M
Weil company	24.77K	0.14%	$641.41K
Fred alger management	1.64M	0.10%	$24.54M
Federated hermes	1.77M	0.08%	$48.15M
Bvf inc/il	65.35K	0.04%	$980.25K

Top Buyers

Holder	Shares	% Assets	Change
Fmr	244.40K	0.00%	244.40K
Federated hermes	1.77M	0.08%	130.14K
Russell investments group	91.77K	0.00%	91.77K
Candriam s.c.a.	84.80K	0.01%	84.80K
Vanguard fiduciary trust	72.09K	0.00%	72.09K

Top Sellers

Holder	Shares	% Assets	Change
Bml capital management	-	-	-1.76M
Bvf inc/il	65.35K	0.04%	-522.99K
Ikarian capital	300.00K	0.45%	-176.44K
Adar1 capital management	-	-	-159.26K
Heights capital management	-	-	-143.03K

New Positions

Holder	Shares	% Assets	Change	Value
Fmr	244.40K	0.00%	244.40K	$3.67M
Russell investments group	91.77K	0.00%	91.77K	$2.38M
Candriam s.c.a.	84.80K	0.01%	84.80K	$2.20M
Vanguard fiduciary trust	72.09K	0.00%	72.09K	$1.87M
Ameriprise financial	69.89K	0.00%	69.89K	$1.05B

Sold Out

Holder	Change
Qube research	-3.00
Jpmorgan chase	-3.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-193.00
Private trust co na	-274.00
Advisor group	-1.08K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	19	-54.76%	2,710,133	-73.80%	15	0.20%	13	-51.85%	3	-40.00%
Sep 30, 2025	15	-54.55%	3,195,999	-67.42%	27	0.39%	11	-52.17%	1	-75.00%
Jun 30, 2025	7	-75.86%	1,313,474	-73.91%	11	0.59%	5	-61.54%	-	-100.00%
Mar 31, 2025	29	11.54%	5,034,503	17.74%	44	0.21%	13	-13.33%	4	-
Dec 31, 2024	26	13.04%	4,275,837	480.46%	146	9.23%	15	650.00%	4	-80.95%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann Growth	1.04M	5.08%	-
Federated Hermes Kaufmann R	1.04M	5.08%	-
Federated Hermes Kaufmann Small Cap Grow	702.40K	3.43%	-
Federated Hermes Kaufmann Small Cap A	702.40K	3.43%	-
Vanguard Total Stock Mkt Idx Inv	393.73K	2.84%	-
Alger Small Cap Focus I	496.06K	2.42%	-
Alger Small Cap Focus Composite	496.06K	2.42%	-
Fidelity Select Biotechnology	340.69K	1.66%	29.73K
Alger Small Cap Growth B	157.75K	1.14%	-
Vanguard Institutional Extnd Mkt Idx Tr	124.88K	0.90%	4.44K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 30, 2025	Riley Antony A	CHIEF FINANCIAL OFFICER	Buy	$254.83K
Nov 21, 2024	Riley Antony A	CHIEF FINANCIAL OFFICER	Buy	$125.00K
Dec 18, 2023	Wagner Paul A.	See Remarks	Buy	$7.53K
Dec 13, 2023	Wagner Paul A.	See Remarks	Buy	$7.35K
Dec 14, 2023	Wagner Paul A.	See Remarks	Buy	$7.20K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	1	-
2025 Q3	-	-
2025 Q2	-	-

FBRX Ownership FAQ

Who Owns Forte Biosciences?

Forte Biosciences shareholders are primarily institutional investors at 15.23%, followed by 4.97% insiders and 79.80% retail investors. The average institutional ownership in Forte Biosciences's industry, Biotech Stocks , is 382.13%, which Forte Biosciences falls below.

Who owns the most shares of Forte Biosciences?

Forte Biosciences’s largest shareholders are Fred alger management (1.64M shares, 13.93%), Orbimed advisors (1.2M shares, 10.19%), and Federated hermes (1.77M shares, 9.92%). Together, they hold 34.04% of Forte Biosciences’s total shares outstanding.

Does Blackrock own Forte Biosciences?

BlackRock is not among the top 10 institutional shareholders of Forte Biosciences.

Who is Forte Biosciences’s biggest shareholder by percentage of total assets invested?

Tybourne capital management (hk) is Forte Biosciences’s biggest shareholder by percentage of total assets invested, with 38.15% of its assets in 786.65K Forte Biosciences shares, valued at 11.8M$.

Who is the top mutual fund holder of Forte Biosciences shares?

Federated Hermes Kaufmann Growth is the top mutual fund holder of Forte Biosciences shares, with 5.08% of its total shares outstanding invested in 1.04M Forte Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools